• If you are wondering whether BrightSpring Health Services is priced attractively or already reflects a lot of optimism, you are not alone in asking whether the current share price lines up with its fundamentals.
• The stock recently closed at US$41.77, and its returns sit at 4.1% over 7 days, 7.0% over 30 days, 8.8% year to date, and 142.4% over 1 year. This naturally raises questions about how much of the story is already in the price.
• Recent news coverage has focused on BrightSpring Health Services as a listed healthcare provider and the role it plays in a sector where scale and service reach matter to investors. This context helps frame why the market may be paying close attention to the stock at current levels.
• On our valuation framework, BrightSpring Health Services has a value score of 3 out of 6, which means some checks point to potential undervaluation while others are more mixed. Next, we will walk through the main valuation methods before finishing with a perspective that aims to give you an even clearer read on what the stock might be worth.

Approach 1: BrightSpring Health Services Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model takes estimates of the cash a company could generate in the future and discounts those amounts back to today, giving a single figure for what the entire business might be worth in present value terms.

For BrightSpring Health Services, the model uses last twelve months free cash flow of about $385 million as a starting point and then applies a 2 Stage Free Cash Flow to Equity approach. Analyst estimates run through 2030, with projected free cash flow of $935.8 million in that year. Beyond the explicit analyst window, Simply Wall St extrapolates further free cash flow paths using its own growth assumptions, still expressed in dollars and remaining below $2 billion in the forecast horizon provided.

Adding up all discounted cash flows results in an estimated intrinsic value of about $145.62 per share. Compared with the recent share price of $41.77, the DCF output suggests BrightSpring Health Services trades at a 71.3% discount, indicating a wide gap between the market price and this model’s estimate of value.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests BrightSpring Health Services is undervalued by 71.3%. Track this in your watchlist or portfolio, or discover 47 more high quality undervalued stocks.

Approach 2: BrightSpring Health Services Price vs Earnings

For profitable companies, the P/E ratio is a useful shorthand for how much investors are currently willing to pay for each dollar of earnings. It pulls together the share price and earnings into a single number that is easy to compare across time and against other stocks.

What counts as a "normal" P/E really depends on how the market views a company’s growth prospects and risk. Higher expected growth or lower perceived risk can justify a higher multiple, while slower growth or higher risk usually lines up with a lower one.

BrightSpring Health Services currently trades on a P/E of 80.63x. That sits above the Healthcare industry average of 22.68x and also above its peer group average of 46.72x, which suggests investors are paying a relatively high multiple compared with these simple benchmarks.

Simply Wall St’s Fair Ratio is a proprietary estimate of what a more appropriate P/E might be once you factor in the company’s earnings growth profile, industry, profit margins, market cap and key risks. This tends to be more tailored than a straight comparison to industry or peer averages because it tries to match the multiple to the company’s own characteristics rather than broad groupings.

For BrightSpring Health Services, the Fair Ratio is 32.43x, which is materially lower than the current 80.63x P/E. On this measure, the stock screens as expensive relative to what the Fair Ratio suggests might be more appropriate.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your BrightSpring Health Services Narrative

Earlier we mentioned that there is an even better way to understand valuation. On Simply Wall St's Community page you can use Narratives to link your own story about BrightSpring Health Services to a set of revenue, earnings and margin forecasts. You can then compare the resulting Fair Value with the current share price to help decide whether you see it as closer to the US$41.0 high-end view or the US$25.0 low-end view. Your Narrative will then update automatically as new news or earnings arrive so your investment thesis always connects a clear storyline to fresh numbers.

For BrightSpring Health Services however we will make it really easy for you with previews of two leading BrightSpring Health Services Narratives:

Each one ties a different story about revenue growth, margins and valuation back to a single fair value estimate, so you can quickly see which feels closer to your own view of the business.

Fair value: US$52.26 per share

Implied discount to this fair value: about 20.1% compared to the recent US$41.77 share price

Revenue growth assumption: 14.85% per year

• Analysts in this camp expect BrightSpring Health Services to grow faster by leaning on specialty pharmacy launches, home and community care expansion and efficiency projects that support higher margins over time.
• The bullish narrative assumes that by 2028, higher earnings and a future P/E of 27.08x can justify an updated fair value around US$52.26, using a 6.98% discount rate.
• Supporters of this view tend to see recent analyst target increases and raised revenue growth assumptions as consistent with a business that can compound earnings at a healthy rate, while accepting exposure to labor costs, funding mix and leverage as key risks to monitor.

Fair value: US$38.00 per share

Implied premium to this fair value: about 9.9% compared to the recent US$41.77 share price

Revenue growth assumption: 13.15% per year

• The bearish narrative leans more heavily on risks such as wage pressures, reliance on government reimbursement and execution around acquisitions, and sees these as limiting how much of that revenue growth will translate into durable earnings.
• On this view, a future P/E of 30.32x applied to more modest earnings expectations, discounted at 6.98%, supports a fair value of US$38.00, which is below the current share price.
• Analysts in this camp typically point to slower utilization trends, policy uncertainty and the need for ongoing reinvestment in technology as reasons why the stock may already price in a lot of optimism.

If you want to see how these stories are built from the ground up and stress test them against your own assumptions, you can step through the full narratives, adjust the inputs and see how the implied fair value shifts over time.

Do you think there's more to the story for BrightSpring Health Services? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.